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ABSTRACT
The budding yeast Saccharomyces cerevisiae is a major model system in the study of aging. Like metazoans, yeast 
lifespan is extended by caloric restriction and treatment with pharmacological agents which extend lifespan. A major 
workhorse of aging research in budding yeast is the chronological lifespan assay. Traditionally, chronological lifespan 
assays consist of taking regular samples of aging yeast cultures, plating out aliquots on agar, and counting the resulting 
colonies. This method, while highly reliable, is labor-intensive and expensive in terms of materials consumed. Here, we 
report a novel MTT-based method for assessing chronological lifespan in yeast. We show that this method is equal to 
the colony counting method in its rigorous and reliable measurement of lifespan extension in yeast as a result of caloric 
restriction, and is able to distinguish known long-lived and short-lived yeast strains. We have further developed this 
method into a high-throughput assay that allows rapid screening of potential anti-aging compounds as well as yeast 
strains with altered lifespan. Application of this method permits the rapid identification of anti-aging activities in yeast 
and may facilitate identification of materials with therapeutic potential for higher animals and, most importantly, humans.
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INTRODUCTION
The budding yeast Saccharomyces cerevisiae is a prominent model 
system in modern biology, particularly for the study of aging and lifes-
pan [1-5]. Yeast combines advantages such as low cost, ease of genetic 
manipulation, and rapid generation time, as well as possessing high 
similarity to metazoans in its response to factors that affect lifespan and 
the evolutionarily conserved nature of genes that influence longevity 
[2-4]. Increased lifespan in eukaryotes is induced by caloric restriction 
(CR) and pharmacological agents which are thought to modulate cellular 
nutrient sensing [6-8]. Caloric restriction is defined as a reduction of 
an organism’s available nutritional energy without inducing malnutri-
tion [6]. In the case of yeast, this means reduction, or alteration of the 
concentration of carbon source used for energy production without 
reducing availability of amino acids, vitamins, or inorganic nitrogen 
sources to inadequate levels [5,8-10]. Pharmacological agents can also 
extend lifespan by mimicking the effects of CR by disrupting the cell’s 
ability to “sense” nutrients within their environment. These agents in-
clude rapamycin and metformin [6,11,12]. Rapamycin disrupts nutrient 
sensing by inhibition of the TOR kinase [12]. Metformin is hypothesized 
to inhibit the mitochondrial respiratory chain, with the net effect of 
reducing cellular energy production (increased AMP/ATP ratios), and 
therefore is also a mimetic of CR [6,11]. In addition to these well-char-
acterized CR mimetics, the dietary polyphenols (-)-epigallocatechin 
gallate (EGCG) and resveratrol have been shown to extend lifespan in 
metazoan model systems including C. elegans and D. melanogaster 
[6]. These compounds are hypothesized to extend lifespan through 
both antioxidant activity and modulation of nutrient sensing pathways 
via activation of Sirtuin proteins [6]. Resveratrol and rapamycin have 
been shown previously to extend lifespan in yeast [13-15]. However, 
neither EGCG nor metformin has been previously investigated for 
lifespan extension in this model system.
How to cite this article: Belak ZR, Harkness T, Eskiw CH. A rapid, high-throughput method for determining chronological lifespan in budding 
yeast. J Biol Methods 2018;5(4):e106. DOI: 10.14440/jbm.2018.272
2 J Biol Methods  | 2018 | Vol. 5(4) | e106
POL Scientific
article
Lifespan in budding yeast is represented by two metrics: replicative 
life span (RLS) —the number of daughter cells produced over the lifetime 
of a given mother cell; and chronological lifespan (CLS) —the length 
of time non-dividing cells survival [1,6,17]. CLS is assayed by growing 
yeast cells to stationary phase followed by periodic removal, dilution, 
and agar plating of aliquots of the aging culture [1]. The resultant colony 
forming units (CFUs) are then used to determine survival curves. This 
is known as the colony counting (CC) chronological lifespan assay. 
While the introduction of automated methods for CC have increased 
the efficiency of this method somewhat, the preparation of potentially 
hundreds of agar plates and the required dilutions and plating are a 
significant burden in terms of time and resources, and this methodology 
is very poorly suited to high-throughput applications. Powers et al. used 
decreases in optical density of yeast cells growing in 96-well plates to 
assess lifespan and this method led to the global identification of yeast 
mutants that alter CLS [15]. The method relies on the gradual decrease 
in optical density in aging cultures due to autolysis of dead cells. This 
technique suffers from the disadvantage that it does not distinguish living 
cells from intact or fragmented dead cells. Furthermore, decreases in 
optical density were marginal at best and can take up to weeks to appear 
significant. We therefore sought to design a new method for assessing 
chronological lifespan in budding yeast that would be inexpensive, 
rapid, accurate, and amenable to high-throughput screening of potential 
anti-aging compounds such as those described above.
One of the most widely used methods for assessing eukaryotic cell 
number are absorbance-based assays based on the conversion by viable 
cells of a tetrazolium compound to a corresponding highly colored for-
mazan product [18,19]. The most common embodiment of these assays 
relies on the reduction of yellow 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide (MTT) to a purple-colored formazan product 
with an absorption peak at 550 nm [18]. In mammalian cells, MTT 
is reduced to the formazan by a number of mitochondrial NAD(P)H 
oxioreductase enzymes, and under defined conditions the increase in 
absorbance of the formazan product at 550 nm is proportional to the 
number of viable cells [19]. The MTT assay has also been applied to 
the determination of cell number of simple eukaryotes such as fungi, 
protozoans, and yeasts, as well as in prokaryotic cells [19]. Previous 
work has reported the use of MTT reduction as an indicator of viability 
in yeasts in the absence of menadione [20-22]. However, it appears that 
many yeast species or strains are unable to efficiently reduce MTT and 
addition of menadione as an intermediate electron acceptor is required 
for efficient MTT reduction [19,23,24]. Jahn and colleagues report a 
simple, high-throughput colorimetric assay for measuring cell con-
centration of the pathogenic yeast Candida albicans in the context of 
antifungal susceptibility testing involving addition of 0.5 mg/ml MTT 
and 0.1 mM menadione to actively growing cultures [24]. Separately, 
Hodgson and colleagues reported that MTT was only effectively reduced 
by actively growing S. cerevisiae cells and formazan formation was 
absent in cultures of stationary phase cells, leading to the conclusion that 
MTT assays are only valuable for proliferating cells [22]. In this publi-
cation, we report the development of a novel yeast rapid chronological 
lifespan (RCL) assay based on these previously reported MTT-based 
assays. We show that in the presence of menadione and glucose the 
assay accurately reflects viable cell number in aging yeast cultures. The 
assay is used to demonstrate the lifespan increasing effect of caloric 
restriction and accurately distinguishes between known long-lived and 
short-lived yeast strains. Finally, we describe a high-throughput RCL 
(HTRCL) assay which permits rapid screening of compounds, yeast 
mutants, or both, for alterations in lifespan. These assays represent a 
substantial improvement in cost, time investment, and capability over 
previous chronological lifespan assays in budding yeast.
MATERIALS AND METHODS
Reagents, media, and yeast strains
Yeast extract, peptone, yeast nitrogen base without amino acids, 
sodium chloride, sodium dihydrogen phosphate, disodium hydrogen 
phosphate, dimethyl sulfoxide (DMSO), and glucose were Fisher® 
Bioreagent® grade, purchased from ThermoFisher Scientific Inc. (Fair-
lawn, NJ, USA). 2-methyl-1,4-naphthoquinone (menadione) and MTT 
were acquired from Acros Organics® (New Jersey, NJ, USA). NP-40, 
2-propanol (HPLC grade), resveratrol, and (-)-epigallocatechin gallate 
(EGCG) were obtained from Sigma-Aldrich® (St. Louis, MO, USA). 
ACS grade hydrochloric acid was purchased from Anachemia Canada 
Co. (Montreal, QC, Canada). Metformin and rapamycin were supplied 
by Santa Cruz Biotechnology Inc. (Dallas, TX, USA). Strains of S. 
cerevisiae used were WT (MATa ade2 his3 leu2 lys2 ura3, [25]), fob1∆ 
(MATa his3 leu2 met15 ura3 fob1Δ::kanMX6, [25]), apc10∆ (MATa 
his3 leu2 met15 ura3 apc10Δ::kanMX6, [26]), apc5CA (MATa ade2 
his3 leu2 ura3 apc5CA-PA::His5, [27]), apc5CA apc10∆ (MATa his3 
leu2 met15 ura3 apc5CA-PA::His5 apc10Δ::kanMX6, [26]), and sch9∆ 
(MATa ade2 his3 leu2 lys2 ura3 sch9Δ::His5, this study). Yeast extract 
peptone dextrose (YPD) (1% w/v yeast extract, 2% w/v peptone, 2% 
w/v glucose), and complete minimal media (CM; 0.67% w/v yeast 
nitrogen base without amino acids, 0.02% w/v complete amino acid 
mixture) were used as described previously [28]. Cell concentrations 
in yeast cultures were assessed by dilution of culture 1/100 in PBS 
(140 mM NaCl, 10 mM sodium phosphate pH 7.4) and cell number 
counted using a Beckman-Coulter Multisizer® 3 Coulter counter. All 
spectrophotometric measurements were made with a BioRad Smartspec® 
plus spectrophotometer. All error bars in the included figures represent 
the standard error of three independent replicates.
Dilution/plating based chronological lifespan assays
Yeast was grown overnight at 30°C in YPD, collected by centrif-
ugation (1500 × G, 5 min, RT), washed in sterile water, centrifuged, 
and resuspended at a concentration of 1 × 107 cells/ml in CM media 
containing either 2% w/v or 0.2% w/v glucose as indicated. Where 
applicable, compounds such as rapamycin were added to cultures 
during the exponential growth phase, before cell reached stationary 
phase. Cultures were then incubated at 30°C with shaking for 48 h to 
allow cells to reach stationary phase, after which cultures began to age 
and the number of viable cells began to decrease [1,28]. Cultures were 
subsequently maintained at 30°C with shaking for the duration of the 
lifespan experiments. At the indicated time points, 100 µl of the culture 
was removed, diluted 1/10000 with distilled water, and 100 µl of the 
resulting dilution plated on YPD agar plates in triplicate for technical 
replicates. After 48 h incubation at 30°C plates were scanned using a 
standard commercially available document scanner (Epson Perfection® 
V300 Photo) and colonies counted using the OpenCFU software [29]. 
To ensure accuracy, some plates were manually counted and in all cases 
the number of colonies was within 1% of the value predicted by the 
OpenCFU software. Data presented is the average of three independent 
J Biol Methods  | 2018 | Vol. 5(4) | e106 3
POL Scientific
article
biological replicates.
Analysis of optimal assay conditions for MTT-based 
chronological lifespan assays
Yeast was grown to stationary phase (72 h) at 30°C in YPD, collect-
ed by centrifugation (1500 × G, 5 min, RT), washed in sterile water, 
centrifuged, and resuspended at a concentration of 1 × 107 cells/ml in 
sterile water. For experiments monitoring the rate of formazan product 
accumulation and the effect of glucose and menadione addition, 2.5 ml of 
the yeast suspension was combined with 2.5 ml of a solution containing 
1 mg/ml of MTT plus the indicated additives (0.2 mM menadione, 4% 
w/v glucose, or both) and incubated at 30°C with shaking. At the indi-
cated time points, 250 µl of the mixture was removed, combined with 
250 µl of solubilization solution (50% v/v 2-propanol, 0.2% NP-40, 20 
mM hydrochloric acid), and placed on an agitator at room temperature 
for 30 min. The resulting solution was then centrifuged (15000 × G, 5 
min, RT) and the absorbance of the resulting supernatants measured at 
a wavelength of 550 nm. For assessing the accumulation of formazan 
product in relation to cell concentration the stationary phase cells ob-
tained as above were resuspended in sterile water at concentrations of 
1 × 107, 5 × 106, 2.5 × 106 or 1.25 × 106 cells/ml in a volume of 2.5 ml, 
combined with 2.5 ml of a solution of 4% glucose, 1 mg/ml MTT and 
0.2 mM menadione, and treated exactly as described above.
Rapid chronological lifespan assay
RCL Reagent Solution contained 4% w/v glucose, 1 mg/ml MTT, 
and 0.2 mM menadione and was filter sterilized and stored at −20°C 
prior to use. Yeast was cultured overnight at 30°C in YPD, collected 
by centrifugation (1500 × G, 5 min, RT), washed in sterile water, 
centrifuged, and resuspended at a concentration of 1 × 107 cells/ml in 
CM media containing either 2% w/v or 0.2% w/v glucose as indicated. 
Cultures were then incubated at 30°C with shaking for 48 h prior to, 
and for the duration of, the lifespan experiments. At the indicated time 
points, 250 µl of the culture was removed and combined with an equal 
volume (250 µl) of RCL Assay Solution and mixed. The mixture was 
then incubated with shaking at 30°C for 4 h. An equal volume (500 
µl) of solubilization solution (50% v/v isopropanol, 0.2% NP-40, 20 
mM hydrochloric acid) was then added and the mixture placed on an 
agitator at room temperature for 30 min. The resulting solution was 
then centrifuged (15000 × G, 5 min, RT) and the absorbance of the 
resulting supernatants measured at a wavelength of 550 nm. Where 
indicated, the student’s t-test was used to compare the average% initial 
absorbance at 550 nm to the average% initial cell number as determined 
by the CC assay.
High throughput rapid chronological lifespan assay
For application of the RCL assay to 96-well plate format, yeast 
cells were grown overnight in YPD at 30°C. Cells were then collected 
by centrifugation (1500 × G, 5 min, RT), washed once in sterile wa-
ter, again collected by centrifugation, and suspended in CM medium 
containing 2% w/v glucose at a concentration of 1 × 107 cells/ml. The 
resulting suspension was aliquoted into 96-well plates (200 µl per well) 
and a range of concentrations of the indicated pharmacological agents 
added in the form of a solution in DMSO or water. DMSO or water 
was added to control wells such that the concentration of vehicle was 
identical in all wells of the plate. Plates were then incubated at 30°C 
for 48 h prior to beginning the assay. This further ensured that the cells 
were undergoing exponential growth in the presence of specific drugs 
prior to HTRCL assays being performed. After 24 h, the plates were 
mixed to ensure even suspension of the cells and 50 µl was removed 
into the wells of a fresh plate. To this replicate plate, 50 µl per well 
of RCL Reagent Solution (see above) was added and the plate mixed. 
Plates were incubated for 4 h at 30°C, 100 µl per well of solubilization 
solution (see above) was added, and plates placed on an agitator at 
room temperature for 30 min. Finally, the absorbance of each well of 
the plate at 550 nm was determined using a Packard® Spectracount® 
model BS10001 plate reader/spectrophotometer.
RESULTS
Determination of optimal conditions for RCL assay
Our first step in developing an MTT-based yeast chronological lifes-
pan assay was to investigate optimal conditions for formazan product 
formation in aging yeast cultures. Aging cells from stationary phase 
cultures were isolated by centrifugation, washed, resuspended in water, 
and employed in assays as described. It has been noted previously that 
some yeast strains are not able to directly reduce MTT to formazan 
product and addition of menadione is required for this transformation 
[19,23,24]. Treatment of aging yeast cultures with MTT in the absence 
of menadione resulted in no appreciable accumulation of formazan 
product even after 12 h of incubation (Fig. 1A). Upon addition of MTT 
in the presence of 0.1 mM menadione, we observed a relatively linear 
increase in absorbance corresponding to formation of the formazan 
product (Fig. 1A). However, the increase in absorbance was gradual, 
with an absorbance of 0.479 ± 0.046 being achieved after 12 h of 
incubation. Formation of formazan product is dependent on cellular 
metabolic activity [19]. As aging cultures become depleted in glucose 
and other nutrients [1], we hypothesized that supplementation of cultures 
with glucose during the assay would increase production of formazan 
product. Indeed, addition of 2% w/v glucose to the MTT assay mixture 
dramatically increased the rate at which formazan product accumulated, 
presumably by permitting living cells to utilize mitochondrial function 
required for formation of formazan product. These data show that 
optimum product formation in aging yeast cultures is achieved in the 
presence of menadione and glucose, and therefore these materials were 
included in the reagent in all subsequent experiments.
Our next goal was to confirm the linear relation between formazan 
product formation and the number of viable cells present. Stationary phase 
yeast cells were resuspended in water at concentrations of 1 × 107, 5 × 
106, 2.5 × 106 and 1.25 × 106 cells/ml, combined with RCL reagent, and 
the accumulation of formazan product followed over 12 h of incubation 
(Fig. 1B). Accumulation of product was essentially linear from one to 
six hours of incubation. Between 6 and 12 h, absorbance values began 
to fluctuate and become non-linear, possibly due to metabolic disruption 
of cells due to accumulated formazan product (Fig. 1B). Based on the 
results of these experiments, we established four hours as the optimal 
incubation time at which concentration of the formazan product was 
most linearly related to cell concentration. This relationship is demon-
strated in Figure 2 where absorbance is plotted against cell number for 
mixtures incubated with the MTT assay solution for 4 h. The relation is 
highly linear over the range examined with an R2 value of 0.998 (Fig. 
2). The data presented in Figure 1 and Figure 2 confirm that menadione 
is required for conversion of MTT to the colored formazan product as 
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reported previously [23,24] and that addition of glucose substantially 
increases the rate of formazan product formation. Finally, the results 
show that four hours is the optimal time for incubation with MTT solution 
to provide the most accurate estimation of cell number. We therefore 
utilized a 4 h incubation in a solution containing final concentrations 
of 2% w/v glucose, 0.5 mg/ml MTT, and 0.1 mM menadione for all 
subsequent experiments.
Figure 1. Determination of optimal rapid chronological lifespan assay conditions. Stationary phase aging yeast cultures were combined with 
MTT-containing assay solution and incubated. At the indicated times aliquots were removed, combined with solubilization reagent, and absorbance de-
termined at 550 nm. A. Accumulation of formazan product in the presence or of menadione (+/-M) and glucose (+/-GLU). B. Accumulation of formazan 
product in presence of both menadione and glucose in the assay medium as a function of cell concentration (M = 106). Error bars represent the standard 
error of three independent replicates.
RCL assays exhibit a relationship between signal and 
viable cell number over time and demonstrate extend-
ed lifespan under conditions of caloric restriction
Previously, the established method for determination of chronological 
lifespan in budding yeast has been to plate a known dilution of the aging 
yeast culture and count the resulting colonies [1], herein referred to as 
the CC method. Our next step in development of the RCL assay was 
to demonstrate that our method accurately reported the proportion of 
viable cells over time via comparison of RCL data with data obtained 
using the classic CC method (Fig. 3 and Fig. S1). Results of CC assays 
are typically represented as the percent of viable cells remaining after 
a given period as compared to the initial maximal number of cells [1] 
and so we similarly chose to express the results of the RCL assay as 
the percent absorbance at a given time relative to the absorbance at 
the initial maximum. Initially, we compared the decrease in viable cell 
number over time of wild-type yeast grown in rich (2% w/v glucose) 
medium using the CC and RCL assays (Fig. 3 and Fig. S1). We found 
a very high degree of correlation between the two assays, with percent 
viability decreasing to 78.9% ± 5.03% (CC) and 79.8% ± 1.4% (RCL) at 
1 d 54.5% ± 5.6% (CC) and 50.4% ± 2.1% (RCL) at 2 d, 14.0% ± 2.9% 
(CC) and 12.7% ± 0.7% (RCL) at 3 d, and finally to 0.11% ± 0.01% 
(CC) and 0% (RCL, no difference in absorbance from blank after 4 h) 
after 5 d of incubation (Fig. 3 and Fig. S1). These data demonstrate that 
the RCL assay gives highly comparable values to the CC assay within 
the measured experimental error.
One of the most powerful factors in increasing lifespan in budding 
yeast and metazoan organisms is caloric restriction (CR) [4,6-10]. Since 
reduction of glucose concentration has been shown to substantially 
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prolong yeast chronological lifespan [5,9,10], we assessed the ability 
of the RCL assay to accurately report cell viability over time under 
conditions of caloric restriction. Comparison between CC and RCL 
assays of calorie restricted yeast showed consistent values obtained by 
the classic CC method and our new RCL assay (Fig. 3 and Fig. S1). 
These data demonstrate the effectiveness of the RCL assay for accu-
rately reporting viable cell number over time in aging yeast cultures 
and its ability to demonstrate extended chronological lifespan of yeast 
subjected to caloric restriction.
Figure 2. Correlation between cell number and absorbance at 550 nm. Stationary phase aging yeast cultures were combined with RCL assay reagent 
containing menadione and glucose, incubated for 4 h, combined with solubilization reagent, and absorbance determined at 550 nm. Mean absorbance 
is plotted on the y-axis against cell concentration on the x-axis. Error bars represent the standard error of three independent replicates.
Figure 3. Analysis of yeast chronological lifespan under conditions of caloric restriction. Stationary phase aging yeast cultures in CM media con-
taining either 2% or 0.2% glucose (GLU), or of cells suspended in water, were incubated for the indicated number of days (x-axis). Each day, an aliquot 
was removed from the culture and subjected to either the traditional CC assay (grey) or the novel RCL assay described here (black). For CC assays, 
viability is expressed as a percent of the mean cell number at day 0, for RCL assays as a percent of the mean absorbance at day 0 (y-axis). Error bars 
represent the standard error of three independent replicates.
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RCL assay demonstrates increased or decreased lifes-
pan of known long- or short-lived yeast mutants
One of the advantages of budding yeast as a model system is the 
ability to easily create and isolate mutant strains in order to better un-
derstand the biochemical pathways that underlie a variety of processes 
including aging [2-4]. Over time, a number of yeast mutants with 
abnormally long or short chronological lifespans have been identified 
and characterized [15,17,27,28,30,31]. These include cells lacking 
FOB1 or SCH9, which confer long life, or cells expressing the short-
lived apc10∆ or apc5CA apc10∆ mutations [17,30,31]. While deletion 
of FOB1 has been previously shown to increase replicative lifespan 
[30], Here we show that it also increases CLS (Fig. 4 and Fig. S2). We 
further established the efficacy of the RCL assay as a measurement of 
chronological lifespan in yeast by applying it alongside the CC assay 
of aging cultures of the above yeast strains (Fig. 4 and Fig. S2). There 
was very high agreement between the proportion of viable cells as 
determined by the CC assay and the RCL assay (Fig. 4 and Fig. S2). In 
comparing percent viability obtained by the CC assay versus the RCL 
assay, all values corresponded within measured experimental error, 
except that the RCL assay reported slightly higher values for sch9∆ 
cells at 1, 2, 4, 6, and 12 days while the RCL assay reported a slightly 
lower value than the CC assay for apc5CA apc10∆ cells at the 2-day 
time point (Fig. 4 and Fig. S2). These slight deviations, while greater in 
magnitude than the experimental errors and therefore significant from 
a statistical point of view (student’s t-test), did not affect the ability of 
the assay to accurately distinguish long-lived from short-lived yeast 
strains and may represent slight metabolic differences between stains. 
Overall, these experiments show that the RCL assay is effective for 
analysis of yeast mutants with altered lifespan.
Figure 4. Analysis of long-lived and short-lived yeast mutants. Stationary phase aging cultures of various known long-lived or short-lived yeast 
strains were prepared in CM containing 2% glucose were incubated for the indicated number of days (x-axis). Each day, and aliquot was removed from 
the culture and subjected to either the traditional CC assay (grey) or the novel RCL assay described here (black). For CC assays, viability is expressed 
as a percent of the mean cell number at day 0, for RCL assays as a percent of the mean absorbance at day 0 (y-axis). Strains are identified above the 
panel. Error bars represent the standard error of three independent replicates.
HTRCL assay demonstrates increased lifespan of yeast 
treated with known pharmacological enhancers of lifes-
pan
One of our primary motivators in developing the RCL assay was to 
devise a method for the rapid screening of pharmacological compounds 
with the ability to increase lifespan. A number of previously identified 
compounds that have been shown to extend lifespan in metazoans 
have also been shown to extend chronological lifespan in budding 
yeast [6,12-15]. Given the advantages of yeast for studies of aging, 
we utilized it as a model for the rapid screening of compounds with 
potential anti-aging activity. To achieve this, we adapted the RCL 
assay to a high-throughput format using 96 well plates. In this assay, 
two candidate compounds can be screened for effects on chronological 
lifespan at ten different concentrations simultaneously on a single plate 
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Briefly, a plate containing the yeast strain of interest and the compound 
of interest at varying concentrations is incubated to the point of stationary 
phase. Then, a portion of the mixture from each well is transferred to a 
second plate and the RCL performed, and finally, 48 h later the mixture 
is subjected to the RCL assay a second time. This gives, for each set 
of four wells, the proportion of viable cells after 48 h relative to the 
initial value and is therefore an indicator of increased or decreased 
chronological lifespan. The above observation that numbers of wild-
type cells in rich media were decreased to approximately 50% after 
48 h (Fig. 3 and Fig. S1) led us to choose this time point for analysis 
in the HTRCL assay. Although we did not observe an alteration in the 
rate of formazan product formation by yeast cells in the presence of the 
pharmacological agents we tested (data not shown), it is possible that 
the presence of these compounds or others could alter this process. To 
normalize these effects, the quantity of formazan produced at the initial 
time point in the presence of the added agent was compared against the 
quantity produced in the same wells 48 h later, any effect of a given 
compound on formazan product formation is cancelled, leaving only 
the difference in viable cell number in the result.
To demonstrate the usefulness of the HTRCL, we treated wild-type 
cells in rich media with four different pharmacological agents known 
to extend chronological lifespan in metazoans: the macrolide mTOR 
inhibitor rapamycin [6,12,14,15] the anti-diabetic drug metformin [1,2]; 
and the dietary polyphenolic compounds EGCG and resveratrol [6,13]. 
The results show that in all four examples viability of cells treated with 
vehicle alone had decreased to between 30% and 45% at 48 h (Fig. 5), 
consistent with what was observed in RCL assays performed above 
(Fig. 3 and Fig. S1). Treatment with rapamycin at concentrations above 
125 nM caused increased cell viability after 48 h with a maximum of 
81.3% ± 3.7% viability retained at a concentration of 1 µM (Fig. 5), 
consistent with previously published data [14,15]. Metformin led to 
increased 48 h viability at concentrations from 3.125 mM to 50 mM 
(Fig. 5), with maximum retention of viability of 65.1% ± 1.9% at 50 mM 
(Fig. 5). To our knowledge, this is the first demonstration of enhanced 
chronological lifespan in budding yeast treated with metformin. The 
well-studied polyphenol EGCG increased the 48 h viability of aging 
yeast cells at concentrations of 7.8 µM to 500 µM (Fig. 5). Maximum 
48 h viability of 77.2% ± 6.9% was observed at 125 µM EGCG, while 
viability decreased slightly at higher concentrations to 52.2% ± 6.4% at 
500 µM (Fig. 5). Another well-studied dietary polyphenol, resveratrol, 
also increased 48 h cell viability in aging cells at concentrations above 
7.8 µM, with maximal effect of 63.6% ± 3.7% viability observed at a 
concentration of 125 µM (Fig. 5). While resveratrol has been shown 
previously to extend lifespan in yeast at similar concentrations [13], so 
far as we are aware these results constitute the first demonstration of 
increased lifespan in yeast in response to EGCG. These results demon-
strate that the HTRCL assay is effective as a tool for initial screening 
of lifespan extending compounds in the budding yeast model system.
Figure 5. Analysis of anti-aging compounds by the high-throughput rapid chronological lifespan assay. A 96-well plate containing wild type yeast 
in CM media containing 2% glucose and the indicated concentrations of either rapamycin, metformin, EGCG, or resveratrol, was incubated to the point 
of stationary phase (0 h). A portion of the mixture from each well was transferred to a second plate, and an equal volume of RCL added followed by 4 h 
incubation. Solubilization reagent was then added to the wells of the replicate plate and the absorbance of each well at 550 nm determined. After 48 h 
further incubation the process was repeated. For each set of wells, the mean absorbance at 48 h was divided by the mean absorbance at 0 h to derive 
the mean% absorbance relative to the initial value (y-axis). The concentrations of the agents used are plotted in log10 scale on the x-axis. Units are nM 
for Rapamycin and µM for Metformin, EGCG, and Resveratrol. Error bars represent the standard error of three independent replicates.
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DISCUSSION
One of the most important methods for analyzing the effects of genetic, 
nutritional, and pharmacologic modifiers of the aging process in yeast 
is the chronological lifespan assay [1,28]. Previously, chronological 
lifespan assays have been conducted using the CC method, whereby 
aliquots of aging yeast cultures are diluted and plated on agar and the 
resulting colonies counted to determine the decrease in viable cells 
over time [1]. Here we describe RCL and HTRCL assays based on the 
conversion of MTT to a colored formazan product which are rapid, 
inexpensive, and highly accurate.
MTT-based assays have been applied previously to determine viable 
cell number in exponentially growing cultures of yeast, but they have 
not previously been applied to aging yeast cells [21,22,24]. The data 
presented in Figure 1 and Figure 2 show that this assay can be effec-
tively extended to measurement of yeast cell numbers in aging cultures, 
providing a method for rapidly assessing yeast chronological lifespan. 
Our data demonstrates that, in the presence of menadione and glucose, 
production of formazan product by aging yeast cells is linear in rela-
tion to cell number (Fig. 2). We have also demonstrated that the novel 
RCL assay is able to accurately demonstrate the previously observed 
extension in yeast chronological lifespan due to caloric restriction (Fig. 
3 and Fig. S1). The RCL assay is also equal to CC assays in its ability 
to distinguish yeast mutants with abnormally short or long lifespans 
(Fig. 4 and Fig. S2). We have further developed this basic RCL assay 
into a high-throughput method using 96-well plates (HTRCL) that 
permits rapid screening of pharmacological compounds with potential 
anti-aging effects (Fig. 5). The HTRCL assay can also be adapted to 
rapid screening for changes in chronological lifespan of yeast mutants 
or transformants, alone or in combination with pharmacological mod-
ifiers of lifespan. Taken together, the data presented demonstrate that 
the RCL and HTRCL assays are equivalent to traditional CC assays in 
their ability to accurately measure chronological lifespan in yeast with 
the added benefits of increased economy, reduced time input, and the 
capacity for high-throughput analysis.
In general, the RCL assay showed slightly less experimental error 
than CC assays and less variability between biological replicates. 
This is likely due to the reduced number of manipulations involved, 
including dilution steps and spreading of yeast suspensions on agar 
plates. A limitation of the RCL assay is that it was unable to detect very 
small numbers of viable cells. For example, after 5 d in culture in 2% 
w/v glucose wild-type cells showed a decrease in viability to 0.11% 
± 0.01% by CC assay but the RCL assay showed no difference from 
blanks containing no cells (Fig. 5). This limitation is unlikely to be 
problematic since in assessing chronological lifespan it is the overall 
rate of decrease in cell viability with time that is of interest and not the 
ability to determine the exact point at which complete loss of viability 
of the culture is achieved [1]. However, in those cases where it is de-
sirable to determine viability of very small numbers of cells or where it 
is necessary to determine the exact point at which complete viability is 
lost the RCL assay may not be appropriate. With respect to the HTRCL 
assay, we did consider that the presence of various pharmacological 
agents could alter the rate of formazan product accumulation, particu-
larly where the compound being tested has the potential to modify or 
lower the metabolic activity of cells. We addressed this concern through 
the design of the assay by comparing the quantity of formazan product 
produced in the presence of the test compound at 0 h to the quantity 
produced in the same wells 48 h later. In this way, any subtle effects 
of the compound or vehicle on MTT metabolism will be compensated 
for to the greatest extent possible. Furthermore, other methods used 
to assess cell proliferation, such as trypan blue or thymidine analogue 
incorporation, result in the same survival curves as MTT. We would also 
emphasize that the HTRCL is meant primarily as a screening tool for the 
identification of compounds and the relevant concentrations of interest 
and that any promising compounds would be subjected to more detailed 
investigation using the RCL or CC assays. This point is underlined by 
our observations of the effect of EGCG on cell viability (Fig. 5). We 
noted that the 48 h viability increased at concentrations of 7.8 µM to 
125 µM and then decreased at concentrations of 250 µM to 500 µM.
These observations reinforce the utility of the HTRCL assay as a 
screening tool for establishing the useful range of concentrations of can-
didate compounds for further study, and avoiding either concentrations 
too low to be effective or so high as to cause toxicity. We would also 
underline that both the RCL and HTRCL assays are highly versatile 
and that the temperature of incubation (30°C), the time of incubation 
in the presence of MTT (4 h), or the time between the initial and final 
measurements in the HTRCL assay (48 h), can be easily altered to 
suit the needs of particular yeast strains or experimental requirements.
In conclusion, the RCL and HTRCL assays described here represent 
novel methods for the analysis of chronological lifespan and rapid 
screening of potential anti-aging compounds in budding yeast. The 
assays described here exhibit high precision and accuracy, and are more 
economical, more rapid, and more amicable to analysis of larger numbers 
of samples in parallel. While an optical density-based, high-throughput 
method for discovery of long-lived yeast strains has been previously 
described [15] the previous assay suffers from low sensitivity, does not 
distinguish living from dead cells, and requires weeks. The HTRCL assay 
described here constitutes a very rapid, accurate, and high-throughput 
method for screening compounds with potential anti-aging effects in 
yeast, or indeed in any model organism. The ability of the HTRCL 
assay to rapidly screen for lifespan extending activity promises the 
potential for identification of numerous novel anti-aging compounds. 
Given the abundance of previous data showing that caloric restriction 
as well as many compounds known to extend lifespan in metazoans also 
extend chronological lifespan in yeast [6,8-10,13-15], it is hoped that 
the ability to rapidly identify anti-aging activity in yeast will facilitate 
identification of materials with therapeutic potential for higher animals 
and, most importantly, humans.
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